Refractory coeliac disease in a country with a high prevalence of clinically-diagnosed coeliac disease

Alimentary Pharmacology and Therapeutics

Volumn 39, Issue 4, 2014, Pages 418-425

  Ilus, T ^a   Kaukinen, K ^a,b   Virta, L J ^c   Huhtala, H ^a   Maki M ^a   Kurppa, K ^a   Heikkinen, M ^d   Heikura, M ^e   Hirsi, E ^f   Jantunen, K ^g   Moilanen, V ^h   Nielsen, C ⁱ   Puhto, M ^j   Polkki H ^k   Vihriala I ^l   Collin, P ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^c SOCIAL INSURANCE INSTITUTION   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^f SOUTH KARELIA CENTRAL HOSPITAL   (Finland)

^g KYMENLAAKSO CENTRAL HOSPITAL   (Finland)

^h SATAKUNTA CENTRAL HOSPITAL   (Finland)

ⁱ VAASA CENTRAL HOSPITAL   (Finland)

^j MIKKELI CENTRAL HOSPITAL   (Finland)

^k Lansi Pohja Central Hospital   (Finland)

^l Keski Pohjanmaa Hospital   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; WEIGHT REDUCTION;

ADULT; AGE FACTORS; CELIAC DISEASE; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 84892894721     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12606     Document Type: Article

References (28)

1. Abdulkarim AS, Bugart LJ, See J, et al,. Etiology of non-responsive coeliac disease: results of a systematic approach. Am J Gastroenterol 2002; 97: 2016-21.
2. Leffler D, Dennis M, Hyett B, et al,. Etiologies and predictors of diagnosis in nonresponsive coeliac disease. Clin Gastroenterol and Hepatol 2007; 5: 445-50.
3. Dewar D, Donnelly S, McLaughlin S, et al,. Coeliac disease: management of persistent symptoms in patients on a gluten-free diet. World J Gastroenterol 2012; 28: 1348-56.
4. Rubio-Tapia A, Murray JA,. Classification and management of refractory coeliac disease. Gut 2010; 59: 547-57.
5. Rubio-Tapia A, Herman ML, Ludvigsson JF, et al,. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc 2012; 87: 732-8.
6. Cellier C, Delabesse E, Helmer C, et al,. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. Lancet 2000; 356: 203-8.
7. Al-toma A, Verbeek WHM, Hadithi M, et al,. Survival in refractory coeliac disease and enteropathy associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 2007; 57: 1373-8.
8. Malamut G, Afchain P, Verkarre V, et al,. Presentation and long-term follow-up of refractory coeliac disease: comparison of type I with type II. Gastroenterology 2009; 136: 81-90.
9. Daum S, Ipczynski R, Schumann M, et al,. High rates of complications and substantial mortality in both types of refractory sprue. Eur J Gastroenterol Hepatol 2009; 21: 66-70.
10. Rubio-Tapia A, Kelly DG, Lahr BD,. Clinical staging and survival in refractory coeliac disease: a single center experience. Gastroenterology 2009; 136: 99-107.
11. Ciacci C, Cirillo M, Cavallaro R, et al,. Long-term follow-up of coeliac adults on gluten-free diet: prevalence and correlates of intestinal damage. Digestion 2002; 66: 178-85.
12. Lee SK, Lo W, Memeo L, et al,. Duodenal histology in patients with coeliac disease after treatment with a gluten-free diet. Gastrointest Endosc 2003; 57: 187-91.
13. Wahab PJ, Meijer JWR, Mulder CJJ,. Histologic follow-up of people with coeliac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol 2002; 118: 459-63.
14. Tursi A, Brandimarte G, Giorgetti GM, et al,. Endoscopic and histological findings in the duodenum of adults with coeliac disease before and after changing to a gluten-free diet: a 2-year prospective study. Endoscopy 2006; 38: 702-7.
15. Bardella MT, Velio P, Cesana BM, et al,. Coeliac disease: a histological follow-up study. Histopathology 2007; 50: 465-71.
16. Lanzini A, Lanzarotto F, Villanacci V, et al,. Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment Pharmacol Ther 2009; 29: 1299-308.
17. Hutchinson JM, West NP, Robins GG, et al,. Long-term histological follow-up of people with coeliac disease in a UK teaching hospital. Q J Med 2010; 103: 511-7.
18. O′Mahoney S, Howdle PD, Losowsky MS,. Management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther 1996; 10: 671-80.
19. West J,. Coeliac disease and its complications. A time traveler's perspective. Gastroenterology 2009; 136: 32-48.
20. Roshan B, Leffler DA, Jamma S, et al,. The incidence and clinical spectrum of refractory coeliac disease in a North American referral center. Am J Gastroenterol 2011; 106: 923-8.
21. Arguelles-Grande C, Brar P, Green P, et al,. Immunohistochemical and T-Cell receptor gene rearrangement analyses as predictors of morbidity and mortality in refractory coeliac disease. J Clin Gastroenterol 2013; 47: 593-601.
22. Virta L, Kaukinen K, Collin P,. Incidence and prevalence of diagnosed coeliac disease in Finland: results of effective case finding in adults. Scand J Gastroenterol 2009; 44: 933-8.
23. Collin P, Huhtala H, Virta L, et al,. Diagnosis of coeliac disease in clinical practice. J Clin Gastroenterol 2007; 41: 152-6.
24. Kurppa K, Lauronen O, Collin P, et al,. Factors associated with dietary adherence in coeliac disease: a nationwide study. Digestion 2012; 86: 309-14.
25. West J, Logan RFA, Hill PG, et al,. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 2003; 52: 960-5.
26. Rubio-Tapia A, Ludvigsson JF, Brantner TL, et al,. The prevalence of coeliac disease in the United States. Am J Gastroenterol 2012; 107: 1538-44.
27. Salmi T, Collin P, Korbonay-Szabo I, et al,. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut 2006; 55: 1746-53.
28. Hollon JR, Cureton PA, Martin ML, et al,. Trace gluten contamination may play role in mucosal and clinical recovery in a subgroup of diet-adherent non-responsive coeliac disease patients. BMC Gastroenterol 2013; 13: 40.